NSAA
RMD icon

Noroian Steven A & Associates’s ResMed RMD Stock Holding History

Noroian Steven A & Associates’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		$1.06M Hold
23,750
– – 3.59% 19
2013
Q4 		$1.12M Sell
23,750
-50
-0.2% -$2.53K 3.87% 18
2013
Q3 		$1.26M Sell
23,800
-1,200
-5% -$58.2K 4.59% 9
2013
Q2 		$1.13M Buy
+25,000
New +$1.19M 4.01% 16

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Noroian Steven A & Associates's RMD Position: Q1 2014 in Review

Noroian Steven A & Associates held its ResMed (RMD) position steady in Q1 2014 at 23,750 shares worth $1.06M. The position accounts for 3.59% of the portfolio, ranked #19.

Noroian Steven A & Associates first reported a position in RMD in Q2 2013 and has held it in 4 quarters since. The position peaked at $1.26M in Q3 2013. 319 funds tracked by Wall St. Rank hold RMD as of Q1 2014.

  • Noroian Steven A & Associates held 23,750 shares of ResMed worth $1.06M as of Q1 2014.
  • Noroian Steven A & Associates left its ResMed share count unchanged in Q1 2014.
  • ResMed made up 3.59% of Noroian Steven A & Associates's portfolio in Q1 2014, its #19 holding.
  • Noroian Steven A & Associates first reported a position in ResMed in Q2 2013 and has held it in 4 quarters since.
  • Noroian Steven A & Associates's ResMed position peaked at $1.26M in Q3 2013.
  • 319 funds tracked by Wall St. Rank held ResMed as of Q1 2014.

Based on Noroian Steven A & Associates's 13F filing for Q1 2014, filed 13 May 2014.